NRLCX
Price
$48.96
Change
+$0.15 (+0.31%)
Updated
Jul 25 closing price
Net Assets
8.3B
RMFEX
Price
$60.79
Change
+$0.27 (+0.45%)
Updated
Jul 25 closing price
Net Assets
110.54B
Interact to see
Advertisement

NRLCX vs RMFEX

Header iconNRLCX vs RMFEX Comparison
Open Charts NRLCX vs RMFEXBanner chart's image
Neuberger Berman Large Cap Value R6
Price$48.96
Change+$0.15 (+0.31%)
VolumeN/A
Net Assets8.3B
American Funds American Mutual R4
Price$60.79
Change+$0.27 (+0.45%)
VolumeN/A
Net Assets110.54B
NRLCX vs RMFEX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
NRLCX vs. RMFEX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRLCX is a Buy and RMFEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFEX has more cash in the bank: 111B vs. NRLCX (8.3B). NRLCX pays higher dividends than RMFEX: NRLCX (2.27) vs RMFEX (1.53). NRLCX was incepted earlier than RMFEX: NRLCX (7 years) vs RMFEX (23 years). RMFEX (0.62) is less costly to investors than NRLCX (0.51). NRLCX is a more actively managed with annual turnover of: 81.00 vs. RMFEX (31.00). NRLCX has a lower initial minimum investment than RMFEX: NRLCX (0) vs RMFEX (250). RMFEX annual gain was more profitable for investors over the last year : 11.74 vs. NRLCX (10.63). NRLCX return over 5 years is better than : 81.87 vs. RMFEX (62.99).
NRLCXRMFEXNRLCX / RMFEX
Total Expense Ratio0.510.6282%
Annual Report Gross Expense Ratio0.510.6282%
Fund Existence7 years23 years-
Gain YTD9.26111.52780%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets8.3B111B7%
Annual Yield % from dividends2.271.53149%
Returns for 1 year10.6311.7491%
Returns for 3 years28.7932.0890%
Returns for 5 years81.8762.99130%
Returns for 10 yearsN/A88.96-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BEAM21.720.77
+3.68%
Beam Therapeutics
ESPR1.510.02
+1.34%
Esperion Therapeutics
BMRN59.01-0.75
-1.26%
BioMarin Pharmaceutical
TOUR0.86-0.02
-2.16%
Tuniu Corp
IMTE1.15-0.11
-8.73%
Integrated Media Technology Limited